U

United Orthopedic Corp
TPEX:4129

Watchlist Manager
United Orthopedic Corp
TPEX:4129
Watchlist
Price: 81.8 TWD 0.12%
Market Cap: NT$7.9B

Wall St Price Targets

Price Targets Summary
United Orthopedic Corp

Wall Street analysts forecast United Orthopedic Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for United Orthopedic Corp is 118.83 TWD with a low forecast of 111.1 TWD and a high forecast of 129.15 TWD.

Lowest Forecast
Price Target
111.1 TWD
36% Upside
Average Forecast
Price Target
118.83 TWD
45% Upside
Highest Forecast
Price Target
129.15 TWD
58% Upside
United Orthopedic Corp Competitors:
Price Targets
ROKU
Roku Inc
2% Upside
GSBC
Great Southern Bancorp Inc
0% Downside

Revenue
Forecast

16% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
16% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 2 years is 19%.

Gross Profit
Forecast

18% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
18% / Year
Past Growth
21% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 2 years is 21%.

Operating Income
Forecast

23% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
23% / Year
Past Growth
23% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 23%. The projected CAGR for the next 2 years is 23%.

Pre-Tax Income
Forecast

24% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss
24% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 24%. The projected CAGR for the next 2 years is 25%.

Net Income
Forecast

23% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
23% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 23%. The projected CAGR for the next 2 years is 24%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is United Orthopedic Corp's stock price target?
Price Target
118.83 TWD

According to Wall Street analysts, the average 1-year price target for United Orthopedic Corp is 118.83 TWD with a low forecast of 111.1 TWD and a high forecast of 129.15 TWD.

What is the Revenue forecast for United Orthopedic Corp?
Projected CAGR
19%

Over the last 13 years, the compound annual growth rate for Revenue has been 16%. The projected CAGR for the next 2 years is 19%.

What is the Gross Profit forecast for United Orthopedic Corp?
Projected CAGR
21%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 2 years is 21%.

What is the Operating Income forecast for United Orthopedic Corp?
Projected CAGR
23%

Over the last 13 years, the compound annual growth rate for Operating Income has been 23%. The projected CAGR for the next 2 years is 23%.

What is the Pre-Tax Income forecast for United Orthopedic Corp?
Projected CAGR
25%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 24%. The projected CAGR for the next 2 years is 25%.

What is the Net Income forecast for United Orthopedic Corp?
Projected CAGR
24%

Over the last 13 years, the compound annual growth rate for Net Income has been 23%. The projected CAGR for the next 2 years is 24%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett